INSIGHTS ON DRUG DEVELOPMENT
-
Advances In Custom Medium Development The Multi-Omics Difference
Spent media analysis continues to be an essential part of many media development workflows. Newer techniques, however, using state-of-the-art analytical technology, are becoming more popular.
-
Welcoming The "Era Of ADCs"
Dr. Loretta Itri sat down to explore the promise of TRODELVY®️ and other antibody-drug conjugates as transformative treatments for a range of malignancies and intractable diseases.
-
The Technology Debate: Single-Use vs. Stainless Steel
In this discussion you will explore the multi-point case for adopting single-use technologies throughout the workflow via an economic, operational, and environmental sustainability lens.
-
Whitepaper: In Vivo Testing Of Nasal Dosage Forms
Explore how innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.
-
Fast And Scalable Fc Quantitation In Supernatants3/24/2025
In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.
-
Top Challenges In Recombinant Protein Purification Process Development3/27/2024
Get insights from process developers working with recombinant proteins that cannot be purified with affinity chromatography.
-
Is Industry Ready To Take A Bite Out Of Obesity?7/15/2024
What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?
-
Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success2/26/2025
By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.
-
Accelerating The Regulatory Approval Process Of Biosimilars5/13/2025
Leverage the power of pharmacodynamic biomarkers to streamline biosimilar development and accelerate regulatory approval with greater efficiency and confidence.
DRUG DEVELOPMENT SOLUTIONS
-
Enhance tablet effectiveness across various dosages with an excipient that offers excellent compressibility and stability for APIs, which eliminates the need for intense processing and provides rapid disintegration.
-
As consumer safety becomes increasingly vital, the analysis of nitrosamine impurities in pharmaceuticals is critical. Classified as probable human carcinogens, nitrosamines pose significant health risks, prompting regulatory bodies like the U.S. Food and Drug Administration (FDA), Health Cananda and the European Food Safety Authority (EFSA) to implement strict guidelines.
-
CDMOs, CMOs, and those working on pilot to scale-up operations can benefit from this single-use solution for chromatographic purification that offers easy integration and versatility in scale.
-
Allow you students to gain practical hands-on experience exploring the following fundamentals of mass spectrometry:
-
Observe the viability of your cells with the field-upgradeable cellular imaging option for the SpectraMax i3/i3x Multi-mode Detection Platform.